Description: Alliance Partners 360
Alliance Partners360, Inc. was established in August 2012 as a wholly owned subsidiary that serves the non-profit, public benefit mission of its parent, Medicines360 , of expanding access to medicines for women regardless of their socioeconomic status, insurance coverage, or geographic location.
Andrea Olariu, MD, PhD oversees Clinical/Medical and Regulatory Affairs, Product Development, and the Quality Department at Medicines360. Since joining Medicines360 in 2010, Dr. Olariu has led the clinical and regulatory strategy resulting in successful FDA approvals of the company’s hormonal IUD, LILETTA.
Dr. Olariu has extensive experience in designing and conducting clinical trials from proof of concept to large pivotal Phase 3 studies. Prior to Medicines360, Andrea developed and implemented clinical/medical and regulatory strategies for several medical devices that received approval in the US, Canada, and the European Union.